China’s Drugs Problem Spells Opportunity for Pharma Giants

Despite escalating global trade tensions, there is at least one area in which China is still opening up—pharmaceuticals.

The country’s Center for Drug Evaluation, China’s version of the Food & Drug Administration, this week made 48 drugs that have already been approved by regulators in the U.S., Japan or Europe eligible for fast-track approval, without additional domestic trials. The move is consistent with Beijing’s policy announced last October to cut red tape around its drug-approval processes.

... Nguồn: www.wsj.com